Consolidation of a small stock is one of many steps in the...

Consolidation of a small stock is one of many steps in the progress of advancement .. Many moves are ahead for MLA. If you read backmy recent posts. ........"Patterson companies. listed on the nasdaq(pdco) has a market cap of four billion $ ..Patterson Veterinary is a division (one of three) of that company ..Patterson Vet. has 21%of the American market, with 245 field professnals spread over 50 states and 140 csr,s working out of 18 branches and a extremly large customer base nation wide..Now they have entered into a partnership with MediVet America" and as we know MLA hold 61% of Med-Amer. Also Pattersons vet. recently purchased the largest company in the UK....No announcements have been put foward by MLA as yet but london to a brick they will be as more detailed info emerges .. The following post is about the future of stem cells and lets not forget animal threapy is the fore runner to this regenerative medicine...... Albany, NY (PRWEB) August 19, 2013

According to a new market report published by Transparency Market Research, “Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural, Umbilical Cord, Cell Production, Cell Acquisition, Expansion, Sub-Culture)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018,“ the market for stem cells was valued at USD 26.23 billion in 2011 and is expected to reach an estimated value of USD 119.51 billion in 2018, growing at a CAGR of 24.2% from 2012 to 2018.

Related Report: Microscopy Devices Market
http://www.transparencymarketresearch.com/microscopy-market.html

The market growth is majorly attributed to therapeutic research activities led by government support worldwide owing to the growing number of patients with chronic diseases across the globe. In addition, rising awareness of regenerative treatment options and growing importance of stem cell banking services are also fostering the growth of the market. Apart from these, development of medical tourism hubs in developing nations such as India and China and in turn migration of patients from developed nations such as the U.S. and Europe for quality treatment at significantly lower prices will also serve the market as a driver especially for the Asian stem cells market.

Related Report: Microscopes Market
http://www.transparencymarketresearch.com/microscopes-market.html

The stem cells market will be driven by rising proportion of patients with neurological and other chronic conditions and rising disposable incomes of patients induced by economic growth of Asian regions in the next five years In addition, increasing dependence on stem cells for drug discovery and screening will boost the growth of the market in the future. Increased outsourcing of contract research and clinical trials to developing Asian regions will further encourage growth of the stem cells market.

Browse: http://udallas.academia.edu/transparencymarketresearch/Papers

Adult stem cells held majority share of the overall stem cells market in 2011 at over 80%. This is due to less laborious procedure of harvesting, and less probability of contamination during expansion and sub-culture of adult stem cells. However, fewer post-transplant complications and lesser risk of graft vs. host reaction from the recently introduced induced pluripotent stem cells will lead to its rapid inclusion in research activities and help the global induced pluripotent stem cells market to grow at a relatively faster CAGR during the forecast period.

Regenerative medicine dominated the stem cells market by applications in 2011, and is expected to maintain its leading position till 2018. Considerable research activities and the resultant developed therapies in neurology will drive the stem cells market in the forecast period.

Browse the full report with TOC at http://www.transparencymarketresearch.com/stem-cells-market.html/.

North America was the market leader of the total stem cells market in 2011 and is expected to maintain its leading position till 2018. North American market is a center for stem cells research owing to greater support offered by federal government, and higher affordability of treatment in the region. High prevalence of chronic diseases in the region and support in terms of funding from government and private organizations is driving the European stem cells market.
Cheers Vin